Patent · US Active

Triazole derivatives

US8093240B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Bertram Cezanne · Mörfelden, DE
Christiane Amendt · Mühltal, DE
Hartmut Greiner · Darmstadt, DE
Ulrich Graedler · Weinheim, DE
Guenter Hoelzemann · Seeheim-Jugenheim, DE

Key dates

Filing date	Nov 24, 2006
Grant date	Jan 10, 2012
Priority date	—
Expiry date	Sep 11, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel triazole derivatives are inhibitors of TGF-beta receptor I kinase, and can be employed, inter alia, for the treatment of tumours.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.